Downregulation of HMGA2 inhibits cellular proliferation and invasion, improves cellular apoptosis in prostate cancer

作者: Junyan Cai , Guangyu Shen , Su Liu , Qingbing Meng

DOI: 10.1007/S13277-015-3853-9

关键词:

摘要: Prostate cancer is the most commonly diagnosed among men and second leading cause of cancer-associated deaths in world. Unfortunately, treatment failures are common due to metastasis chemoresistance, but underlying molecular mechanism remains unclear. Accumulating evidence has indicated that deregulation DNA-binding protein High Mobility Group A2 (HMGA2) associated with development progression cancer. This study aimed explore expression HMGA2 prostate tissues its correlation clinical pathology cancer, discuss role The results showed messenger RNA (mRNA) cells was significantly higher than normal (p < 0.05), positive rate mRNA from patients lymph node or high Gleason grade negative low (p < 0.05). In order human PC3 cell line downregulated by interference. Then, changes proliferation, apoptosis, invasion, migration were examined MTT test, PI staining, Annexin V-FITC Transwell chamber assay. Results abilities suppressed knockdown cells, apoptosis enhanced cells. cyclin A vimentin caspase 3 E-cadherin upregulated Taken together, overexpression might be related tumorigenesis, downregulation could inhibit cellular metastasis, improve which a potential target for

参考文章(20)
A Patrikidou, Y Loriot, J-C Eymard, L Albiges, C Massard, E Ileana, M Di Palma, B Escudier, K Fizazi, Who dies from prostate cancer Prostate Cancer and Prostatic Diseases. ,vol. 17, pp. 348- 352 ,(2014) , 10.1038/PCAN.2014.35
JUNHYUN LEE, SHINJUNG HA, CHAN-KWON JUNG, HAN HONG LEE, High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. International Journal of Oncology. ,vol. 46, pp. 2431- 2438 ,(2015) , 10.3892/IJO.2015.2947
Kyung-Rok Yu, Sang-Bum Park, Ji-Won Jung, Min-Soo Seo, In-Sun Hong, Hyung-Sik Kim, Yoojin Seo, Tae-Wook Kang, Jin Young Lee, Andreas Kurtz, Kyung-Sun Kang, HMGA2 regulates the in vitro aging and proliferation of human umbilical cord blood-derived stromal cells through the mTOR/p70S6K signaling pathway. Stem Cell Research. ,vol. 10, pp. 156- 165 ,(2013) , 10.1016/J.SCR.2012.11.002
DONG LI, LI-NAN ZHAO, XIU-LAN ZHENG, PING LIN, FENG LIN, YUE LI, HAI-FENG ZOU, RONG-JUN CUI, HUI CHEN, XIAO-GUANG YU, Sox2 is involved in paclitaxel resistance of the prostate cancer cell line PC-3 via the PI3K/Akt pathway. Molecular Medicine Reports. ,vol. 10, pp. 3169- 3176 ,(2014) , 10.3892/MMR.2014.2630
Hyun Min Song, Jae Eun Lee, Jung Hwa Kim, Ubiquitin C-terminal hydrolase-L3 regulates EMT process and cancer metastasis in prostate cell lines Biochemical and Biophysical Research Communications. ,vol. 452, pp. 722- 727 ,(2014) , 10.1016/J.BBRC.2014.08.144
Youyou Xia, Xia He, Li Yin, Hao Tian, WenJie Guo, Ning Jiang, Xuesong Jiang, Jing Wu, Meng Chen, Jianzhong Wu, HMGA2 is associated with epithelial&ndash;mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma OncoTargets and Therapy. ,vol. 8, pp. 169- 176 ,(2015) , 10.2147/OTT.S74397
Scott M. Hammond, Norman E. Sharpless, HMGA2, MicroRNAs, and Stem Cell Aging Cell. ,vol. 135, pp. 1013- 1016 ,(2008) , 10.1016/J.CELL.2008.11.026
Timo Kiljunen, Aki Kangasmäki, Aili Aaltonen, Kalevi Kairemo, Kaarina Partanen, Greetta Joensuu, Tuomo Alanko, Leila Vaalavirta, Timo Joensuu, VMAT technique enables concomitant radiotherapy of prostate cancer and pelvic bone metastases Acta Oncologica. ,vol. 54, pp. 847- 853 ,(2015) , 10.3109/0284186X.2014.962665
Béatrice Dirat, Isabelle Ader, Muriel Golzio, Fabienne Massa, Amel Mettouchi, Kathiane Laurent, Frédéric Larbret, Bernard Malavaud, Mireille Cormont, Emmanuel Lemichez, Olivier Cuvillier, Jean François Tanti, Frédéric Bost, Inhibition of the GTPase Rac1 Mediates the Antimigratory Effects of Metformin in Prostate Cancer Cells Molecular Cancer Therapeutics. ,vol. 14, pp. 586- 596 ,(2015) , 10.1158/1535-7163.MCT-14-0102
Harpreet Kaur, Marianne Hütt-Cabezas, Melanie F. Weingart, Jingying Xu, Yasumichi Kuwahara, Anat Erdreich-Epstein, Bernard E. Weissman, Charles G. Eberhart, Eric H. Raabe, The chromatin-modifying protein HMGA2 promotes atypical teratoid/rhabdoid cell tumorigenicity. Journal of Neuropathology and Experimental Neurology. ,vol. 74, pp. 177- 185 ,(2015) , 10.1097/NEN.0000000000000161